{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0013440/OMIM:613818","label":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","mondoId":"MONDO:0013440","onsetQualifier":null,"recordKeys":["339b0fbc9c7daf88786d4aff3abeadf63819d95d81c1298f6f43ca90845bca90","559066662323322d37a903b312f064b42fe2f74dce884254b5e97633ed2ce656","5bef8c41a1756a610a0a584f7ce63ea3ccfc4b1d21cd3297f217fcf44ff787c6","77e934cdfa91d697e92b1d36b18386add8c077d17e6cc31584e8015430bd7dd5","83bd11525388e3fb4cc2e8d08ad2a5a20f75d65fdf41d455d5acac5df4956720","88b056e40cb5012d3e33354ddb39572c66dfacc5616cb548fb6ecee58e2ccac3","8bf20d2518adf31cea54bc9b6de624cca2fc423405398c00278f967a204df590","9f5c8b2339ffbb1e56a0d91fd19dc58c8e40cdc8ca21a4af7b12e7e989e35606","a6e5c069acde7b8fe10f0dbca34b0edc9018301b0c362f41468f0718b504c7b7","aa9dc6e87f039372cbfa0b3f9704e1fb55b4b5c2071d72640ead9f5fa467bd5a","b2541e61bee6364b1acd9c0a49d59865a8bbd3cc9cc768bec228624da9bcb650","c62a846a9137e36eac1d1178365017216b9ed4967961c1a118bd0b49747c8a30","ceeb168542d1d860d7ec61efcb2dcaf5624760274419d26ea36efb6c67a7968d"],"recordQualifiers":{},"scopeLabel":"OMIM:613818","sourceIds":["OMIM:613818"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0013440/ORPHA:280333","label":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","mondoId":"MONDO:0013440","onsetQualifier":null,"recordKeys":["0c5f1ff3c312367c72f0bc142a8db6b128c5e047208fa6e16f9d9d6472c38914","1c0f8e8e6a8730a81dcc4121f1e8337c5163448d05414a25f8e2adc71afdc9cd","31723fcff706ed1ab4b754aaa6867be9391c0990bb951ea520c17ee352e19cbc","31936b2fa28f7f2345340b1a76e68a392202ca224edd15cc2020e3b1e0c24f8f","348cc3766cea3481a2b4ef2fd5cf874b86fb48eabf36b94f4d43795d6f3740ba","43793afe5d622e30644b398b32638063cf2398061b10637e911fdc4f0fdd087b","60a0f6dd717de4ed689880150ea01f76cc1bd5a987dc4427d9a94dca17649e21","6c44f48ec7da739841fc47412fa51cafe60cb91f637394c39980adb27e497607","9a18753dad54df05d6d71179969aaf47b0341e4962c54af552169873814e825c","b45ad47cc241fa321c7c39dc84f9225c0e365e5b612dca84791606ea0043d136","b4bbc2d03215d5ee6caeba87ba9f725ac90dfdb2280af3881e27b7b647c0c4bb","ca6e6b135b679a0c1fd232cda917ba51ca3c1ef928f10b3764bd1816d9c40871","cac4ff3dbd2077522b065c79c0b622e52a8a4a511c44c986e9ea5b3eaaa603dd","ed5b5a478c791bea115f1b6ad6aed8f50eb0a96edea0eaf7dd84ce43aad3fad7","f66809d0179593d2b950229ff447f4e4ecb2d251b83648a5ab232f93423f7801"],"recordQualifiers":{},"scopeLabel":"ORPHA:280333","sourceIds":["ORPHA:280333"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0013440/OMIM:613818","MONDO:0013440/ORPHA:280333"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":28,"sourceGroups":{"omim":1,"orphanet":15,"published":12}},"features":[{"hpoId":"HP:0006466","label":"Ankle flexion contracture","primary":false},{"hpoId":"HP:0008981","label":"Calf muscle hypertrophy","primary":false},{"hpoId":"HP:0003707","label":"Calf muscle pseudohypertrophy","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language","primary":false},{"hpoId":"HP:0003551","label":"Difficulty climbing stairs","primary":false},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0003391","label":"Gowers sign","primary":false},{"hpoId":"HP:0030046","label":"Hypoglycosylation of alpha-dystroglycan","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0003325","label":"Limb-girdle muscle weakness","primary":false},{"hpoId":"HP:0006785","label":"Limb-girdle muscular dystrophy","primary":false},{"hpoId":"HP:0002938","label":"Lumbar hyperlordosis","primary":false},{"hpoId":"HP:0001256","label":"Mild intellectual disability","primary":false},{"hpoId":"HP:0001270","label":"Motor delay","primary":false},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":false},{"hpoId":"HP:0002465","label":"Poor speech","primary":false},{"hpoId":"HP:0030099","label":"Reduced muscle fiber alpha dystroglycan","primary":false},{"hpoId":"HP:0010864","label":"Severe intellectual disability","primary":false},{"hpoId":"HP:0002317","label":"Unsteady gait","primary":false},{"hpoId":"HP:0002515","label":"Waddling gait","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0013440","records":[{"frequencyKind":"range","key":"0c5f1ff3c312367c72f0bc142a8db6b128c5e047208fa6e16f9d9d6472c38914","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0006785","is_excluded":false,"label":"Limb-girdle muscular dystrophy","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1c0f8e8e6a8730a81dcc4121f1e8337c5163448d05414a25f8e2adc71afdc9cd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003551","is_excluded":false,"label":"Difficulty climbing stairs","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"31723fcff706ed1ab4b754aaa6867be9391c0990bb951ea520c17ee352e19cbc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002465","is_excluded":false,"label":"Poor speech","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"31936b2fa28f7f2345340b1a76e68a392202ca224edd15cc2020e3b1e0c24f8f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0010864","is_excluded":false,"label":"Severe intellectual disability","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"339b0fbc9c7daf88786d4aff3abeadf63819d95d81c1298f6f43ca90845bca90","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"348cc3766cea3481a2b4ef2fd5cf874b86fb48eabf36b94f4d43795d6f3740ba","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003391","is_excluded":false,"label":"Gowers sign","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"43793afe5d622e30644b398b32638063cf2398061b10637e911fdc4f0fdd087b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0006466","is_excluded":false,"label":"Ankle flexion contracture","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"559066662323322d37a903b312f064b42fe2f74dce884254b5e97633ed2ce656","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003551","is_excluded":false,"label":"Difficulty climbing stairs","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"5bef8c41a1756a610a0a584f7ce63ea3ccfc4b1d21cd3297f217fcf44ff787c6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003391","is_excluded":false,"label":"Gowers sign","onset_id":null,"reference":"OMIM:613818","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"60a0f6dd717de4ed689880150ea01f76cc1bd5a987dc4427d9a94dca17649e21","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6c44f48ec7da739841fc47412fa51cafe60cb91f637394c39980adb27e497607","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0030099","is_excluded":false,"label":"Reduced muscle fiber alpha dystroglycan","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"77e934cdfa91d697e92b1d36b18386add8c077d17e6cc31584e8015430bd7dd5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002938","is_excluded":false,"label":"Lumbar hyperlordosis","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"83bd11525388e3fb4cc2e8d08ad2a5a20f75d65fdf41d455d5acac5df4956720","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003325","is_excluded":false,"label":"Limb-girdle muscle weakness","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"88b056e40cb5012d3e33354ddb39572c66dfacc5616cb548fb6ecee58e2ccac3","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8bf20d2518adf31cea54bc9b6de624cca2fc423405398c00278f967a204df590","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"9a18753dad54df05d6d71179969aaf47b0341e4962c54af552169873814e825c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002515","is_excluded":false,"label":"Waddling gait","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"9f5c8b2339ffbb1e56a0d91fd19dc58c8e40cdc8ca21a4af7b12e7e989e35606","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002317","is_excluded":false,"label":"Unsteady gait","onset_id":"HP:0011463","reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a6e5c069acde7b8fe10f0dbca34b0edc9018301b0c362f41468f0718b504c7b7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0030046","is_excluded":false,"label":"Hypoglycosylation of alpha-dystroglycan","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"aa9dc6e87f039372cbfa0b3f9704e1fb55b4b5c2071d72640ead9f5fa467bd5a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b2541e61bee6364b1acd9c0a49d59865a8bbd3cc9cc768bec228624da9bcb650","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b45ad47cc241fa321c7c39dc84f9225c0e365e5b612dca84791606ea0043d136","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002938","is_excluded":false,"label":"Lumbar hyperlordosis","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b4bbc2d03215d5ee6caeba87ba9f725ac90dfdb2280af3881e27b7b647c0c4bb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008981","is_excluded":false,"label":"Calf muscle hypertrophy","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"c62a846a9137e36eac1d1178365017216b9ed4967961c1a118bd0b49747c8a30","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0006466","is_excluded":false,"label":"Ankle flexion contracture","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ca6e6b135b679a0c1fd232cda917ba51ca3c1ef928f10b3764bd1816d9c40871","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001256","is_excluded":false,"label":"Mild intellectual disability","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cac4ff3dbd2077522b065c79c0b622e52a8a4a511c44c986e9ea5b3eaaa603dd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002317","is_excluded":false,"label":"Unsteady gait","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"ceeb168542d1d860d7ec61efcb2dcaf5624760274419d26ea36efb6c67a7968d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613818","disease_name":"Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:21388311","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ed5b5a478c791bea115f1b6ad6aed8f50eb0a96edea0eaf7dd84ce43aad3fad7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003707","is_excluded":false,"label":"Calf muscle pseudohypertrophy","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f66809d0179593d2b950229ff447f4e4ecb2d251b83648a5ab232f93423f7801","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:280333","disease_name":"Alpha-dystroglycan-related limb-girdle muscular dystrophy R16","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001270","is_excluded":false,"label":"Motor delay","onset_id":null,"reference":"ORPHA:280333","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2p","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"autosomal recessive limb-girdle muscular dystrophy type 2P"},"schemaVersion":1}